Vaccination against GnRH as a prelude to surgical castration of horses.
Authors: Birrell John R, Schulman Martin L, Botha Alma E, Ganswindt André, Fosgate Geoffrey T, Bertschinger Henk J
Journal: Equine veterinary journal
Summary
# Vaccination Against GnRH as a Prelude to Surgical Castration of Horses Surgical castration remains one of the most common equine procedures, yet post-operative complications—particularly local swelling—continue to present significant clinical challenges. Researchers in South Africa conducted a randomised controlled trial using Improvac®, an anti-GnRH vaccine, to investigate whether pre-castration vaccination could reduce testicular volume and subsequently decrease complication rates in 19 light horse breed colts. Two vaccine doses administered 28 days apart achieved substantial testicular volume reductions of 49.7% and 63.9% by castration day (at 57 and 100 days post-first vaccination, respectively), with vaccinated colts maintaining baseline testosterone whilst developing robust anti-GnRH antibody responses. Critically, testicular size correlated significantly with post-surgical preputial swelling (P = 0.001) and scrotal swelling (P = 0.025), with vaccinated groups experiencing markedly reduced local inflammation during the 10-day post-operative monitoring period. Although limited by a small pilot cohort, these findings suggest that pre-castration GnRH vaccination offers a practical field-based strategy to mitigate post-operative swelling and associated complications, potentially reducing recovery time and improving outcomes for field castration cases.
Read the full abstract on PubMed
Practical Takeaways
- •Pre-castration vaccination with anti-GnRH vaccine can reduce testicular size and substantially decrease post-surgical swelling complications in field castrations
- •Administer two vaccine doses 28 days apart with castration performed 28-100 days after the first dose for optimal results
- •This approach may reduce pain, infection risk, and complications in colts undergoing surgical castration, improving recovery outcomes
Key Findings
- •Two doses of anti-GnRH vaccine (Improvac®) administered 28 days apart reduced testicular volume by 49.7% at Day 57 and 63.9% at Day 100
- •Vaccinated colts maintained baseline serum testosterone concentrations at castration despite testicular reduction
- •Testis size was significantly correlated with post-surgical preputial swelling (P=0.001) and scrotal swelling (P=0.025)
- •Anti-GnRH vaccination prior to castration significantly reduced the incidence and degree of local post-surgical swelling complications